Related Experiment Video
Updated: Jun 26, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Atheroma progression in chronic kidney disease
Claudio Rigatto1, Adeera Levin, Andrew A House
1University of Manitoba, 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada. crigatto@sbgh.mb.ca
Insights
Cardiovascular disease risk is high in chronic kidney disease (CKD). This study found atherosclerotic plaque growth is not faster in severe CKD, suggesting other factors drive cardiovascular events in these patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is significantly more prevalent in patients with chronic kidney disease (CKD).
- The relationship between the severity of CKD and the rate of atherosclerotic plaque progression remains unclear.
Purpose of the Study:
- To investigate whether atherosclerotic plaque growth is accelerated in patients with severe versus moderate chronic kidney disease.
- To test the hypothesis that lower renal function is associated with faster plaque progression.
Main Methods:
- Prospective cohort study of 318 prevalent CKD patients with creatinine clearance (CCr) between 20-50 ml/min/1.73 m(2).
- Bilateral carotid ultrasonography was used to measure plaque area every 6 months.
- Multiple linear regression analysis assessed the association between CCr quintiles and the rate of change in plaque area.
Main Results:
- The rate of atherosclerotic plaque progression was lower in patients with the lowest CCr (severe CKD).
- Median plaque growth was 0.4 mm(2)/yr in the lowest CCr quintile (< 23 ml/min/1.73 m(2)) compared to 5.0 mm(2)/yr in the highest quintile (> 43 ml/min/1.73 m(2)).
- This inverse association remained significant after adjusting for confounders.
Conclusions:
- Accelerated atherosclerotic plaque growth was not observed in patients with low renal function (severe CKD).
- The findings suggest that mechanisms beyond plaque growth contribute to the elevated cardiovascular disease burden in CKD patients.
Background And Objectives:
Cardiovascular events are 10 to 100 times more frequent in chronic kidney disease (CKD). We tested the hypothesis that the rate of atherosclerotic plaque growth is faster in severe versus moderate CKD.
Design, Setting, Participants, & Measurements:
We performed a prospective cohort study in 318 prevalent CKD patients with initial creatinine clearance (CCr) between 20 and 50 ml/min/1.73 m(2). Baseline clinical and laboratory data were obtained on all patients. Plaque area was determined every 6 mo using bilateral carotid ultrasonography. Plaque area distribution was normalized using a cube root transformation. Unadjusted and adjusted associations between CCr quintiles and rate of change in the transformed plaque area were assessed using multiple linear regression.
Results:
The rate of plaque progression appeared lower in patients with the lowest CCr. Median rate of plaque growth was 0.4 mm(2)/yr in the lowest quintile of CCr (< 23 ml/min/1.73 m(2)) versus 5.0 mm(2)/yr in the highest quintile (> 43 ml/min/1.73 m(2)). This association remained significant after adjustment for potential confounders. A secondary analysis using quintiles of Modification of Diet in Renal Disease (MDRD) GFR confirmed the absence of increased plaque growth at low GFR, although a reduced rate of growth in the lowest quintile of MDRD GFR was not observed.
Conclusion:
We did not observe accelerated plaque growth at low levels of renal function. We suggest that mechanisms other than plaque growth are responsible for the observed excess of cardiovascular disease in CKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Atherosclerosis I: Introduction
Diabetic Nephropathy

